4.5 Article

AAV-p40 Bioengineering Platform for Variant Selection Based on Transgene Expression

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning

Mathieu Nonnenmacher et al.

Summary: A new RNA-driven screening platform called TRACER has been developed to rapidly select AAV capsids with robust BBB penetration and CNS tropism in nontransgenic animals. This method effectively addresses the challenge of therapeutic payload delivery to the central nervous system.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)

Article Biochemistry & Molecular Biology

Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species

Mohammadsharif Tabebordbar et al.

Summary: Evolved capsid variants of AAVs show enhanced potency and therapeutic efficacy for delivering genetic modifiers to muscle tissues, surpassing naturally occurring AAV capsids in mouse models of genetic muscle disease. These engineered vectors demonstrate conserved efficacy across different mouse strains, cynomolgus macaques, and human primary myotubes, indicating a promising approach for gene therapy.
Article Virology

Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids

Mario Mietzsch et al.

Summary: Novel Rep hybrids from different AAV serotypes can significantly reduce the percentage of empty capsids in various AAV serotypes, while improving the yields of genome-containing AAV capsids. These Rep chimeras have the potential to revolutionize rAAV production and enhance the therapeutic efficacy of AAV-based gene therapies.

JOURNAL OF VIROLOGY (2021)

Article Medicine, Research & Experimental

Single amino acid insertion allows functional transduction of murine hepatocytes with human liver tropic AAV capsids

Marti Cabanes-Creus et al.

Summary: The study investigates the differential interspecies transduction abilities among AAV variants, identifying a key residue at a specific position through domain swapping strategies, and proposes the generation of AAV surrogates using this insertion for toxicology and dosing studies in the murine liver model.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)

Article Biotechnology & Applied Microbiology

Adeno-Associated Virus Serotype-Specific Inverted Terminal Repeat Sequence Role in Vector Transgene Expression

Lauriel F. Earley et al.

HUMAN GENE THERAPY (2020)

Article Biotechnology & Applied Microbiology

Pre-arrayed Pan-AAV Peptide Display Libraries for Rapid Single-Round Screening

Kathleen Boerner et al.

MOLECULAR THERAPY (2020)

Review Gastroenterology & Hepatology

Art of Making Artificial Liver: Depicting Human Liver Biology and Diseases in Mice

Go Sugahara et al.

SEMINARS IN LIVER DISEASE (2020)

Article Biochemical Research Methods

Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types

Sripriya Ravindra Kumar et al.

NATURE METHODS (2020)

Letter Biotechnology & Applied Microbiology

AAV Vectors: Are They Safe?

Arun Srivastava

HUMAN GENE THERAPY (2020)

Article Medicine, Research & Experimental

Cross-Packaging and Capsid Mosaic Formation in Multiplexed AAV Libraries

Pauline F. Schmit et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)

Article Medicine, Research & Experimental

Attenuation of Heparan Sulfate Proteoglycan Binding Enhances In Vivo Transduction of Human Primary Hepatocytes with AAV2

Marti Cabanes-Creus et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)

Article Cell Biology

Restoring the natural tropism of AAV2 vectors for human liver

Marti Cabanes-Creus et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Review Biotechnology & Applied Microbiology

Adeno-associated virus vector as a platform for gene therapy delivery

Dan Wang et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Article Medicine, Research & Experimental

Codon-Optimization of Wild-Type Adeno-Associated Virus Capsid Sequences Enhances DNA Family Shuffling while Conserving Functionality

Marti Cabanes-Creus et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)

Review Medicine, Research & Experimental

Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors

Hildegard Buning et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)

Article Multidisciplinary Sciences

A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism

Marcus Davidsson et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Medicine, Research & Experimental

Selection of an Efficient AAV Vector for Robust CNS Transgene Expression

Killian S. Hanlon et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)

Article Biotechnology & Applied Microbiology

Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity

Nicole K. Paulk et al.

MOLECULAR THERAPY (2018)

Review Biotechnology & Applied Microbiology

Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward

Jean Bennett

MOLECULAR THERAPY (2017)

Article Medicine, General & Internal

Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy

J. R. Mendell et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Biotechnology & Applied Microbiology

Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain

Benjamin E. Deverman et al.

NATURE BIOTECHNOLOGY (2016)

Article Neurosciences

A Designer AAV Variant Permits Efficient Retrograde Access to Projection Neurons

D. Gowanlock R. Tervo et al.

NEURON (2016)

Article Multidisciplinary Sciences

Selection and evaluation of clinically relevant AAV variants in a xenograft liver model

Leszek Lisowski et al.

NATURE (2014)

Review Biochemistry & Molecular Biology

Intracellular transport of recombinant adeno-associated virus vectors

M. Nonnenmacher et al.

GENE THERAPY (2012)

Editorial Material Biotechnology & Applied Microbiology

Endgame: Glybera Finally Recommended for Approval as the First Gene Therapy Drug in the European Union

Seppo Ylae-Herttuala

MOLECULAR THERAPY (2012)

Review Microbiology

Innate immune responses to AAV vectors

Geoffrey L. Rogers et al.

FRONTIERS IN MICROBIOLOGY (2011)

Article Biochemistry & Molecular Biology

The alpha-1-antitrypsin gene promoter in human A549 lung derived cells, and a novel transcription initiation site

Kevin Morgan et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)

Article Biotechnology & Applied Microbiology

Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice

Hisaya Azuma et al.

NATURE BIOTECHNOLOGY (2007)

Article Biotechnology & Applied Microbiology

Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors

OJ Müller et al.

NATURE BIOTECHNOLOGY (2003)